Males 20.4%
7.1 19.2%
3.3%
- Income group: Low
Total population: 12,448,000
Life expectancy at birth: Total:51 Males:50 Females:52 Total deaths: 174,000
Chad
Cancer Incidence**
Age-Standardized Cancer Mortality Trends*
Cancer Mortality Profile*
World Health Organization - Cancer Country Profiles, 2014.
Adult Risk Factors
Females
Physical inactivity (2010) Obesity (2014)
Household solid fuel use (2012)
Total 12%
4.4 22.0%
6.6%
93.0%
3.8%
1.8 24.8%
9.9%
- Current tobacco smoking (2011)
Total alcohol per capita consumption, in litres of pure alcohol (2010)
No data available No data available
No data available No data available
No data available No data available
Breast 28.3%
Cervix uteri 18.3%
Ovary 6.1%
Liver 5.3%
Lymphomas, multiple myeloma
4.4%
Other 37.6%
0 5 10 15 20 25 30
2000 2002 2004 2006 2008 2010 2012
age-standardized death rate per 100,000
Prostate Liver
Mouth and oropharynx Lymphomas, multiple myeloma
Colorectum
Females
Prostate 18.5%
Liver 14.7%
Mouth and oropharynx 8.4%
Lymphomas, multiple myeloma
8.0%
Colorectum 5.8%
Other 44.5%
Males
2,000 Deaths
2,500 Deaths
0 5 10 15 20 25 30
2000 2002 2004 2006 2008 2010 2012
age-standardized death rate per 100,000
Breast Cervix uteri
Ovary Liver
Lymphomas, multiple myeloma
Females Males
1,274
630
201 195
140
0 200 400 600 800 1,000 1,200 1,400
Breast Cervix uteri Non-Hodgkin lymphoma
Ovary Liver
Number of cases
Males Females
420
307 258
144 112
0 200 400 600 800 1,000 1,200 1,400
Prostate Liver Non-Hodgkin
lymphoma
Colorectum Leukaemia
Number of cases
Cervical cancer
Harmful use of alcohol prevention and control Physical inactivity prevention and control
Cancer Screening and Early Detection
ND
Has an operational policy, strategy or action plan to reduce physical inactivity and/or promote
physical activity ND
Has an operational policy, strategy or action plan to reduce the harmful use of alcohol ND
Human Papillomavirus vaccination schedule . . .
. . . Hepatitis B vaccination coverage, infants
World Health Organization - Cancer Country Profiles, 2014.
… = No data available
ND = Country did not respond to country capacity survey ND Has an operational policy, strategy or action plan to reduce the burden of tobacco use ND
All public places completely smoke-free (or at least 90% of the population covered by complete subnational smoke-free legislation)***
Smoke-free legislation
Tobacco dependence treatment NRT and/or some cessation services (at least one of which is cost-covered)
Warning labels Medium size warnings missing some appropriate characteristics OR large
warnings missing many appropriate characteristics
Bans on advertising, promotion and sponsorship Ban on all forms of direct and indirect advertising***
. . .
Cancer Treatment and Palliative Care
Cervical cytology (PAP)
Community/home care for people with advanced stage cancer and other NCDs Chemotherapy (medicines not specified)
Oral morphine (formulation not specified)
ND
Cancer Plans, Monitoring and Surveillance
ND ND ND Coverage
Last year of data Has a cancer registry
*** Indicates highest possible level of achievement
Breast cancer
ND
Faecal occult blood test or faecal immunological test Colorectal cancer
Tobacco taxes ≤25% of retail price is tax
Has an operational policy, strategy or action plan for reducing overweight/obesity
48%
ND
ND
Breast palpation / clinical breast exam (CBE) ND
ND
ND
ND
Overweight and obesity prevention and control
National immunization
ND
Non-methadone morphine equivalent consumption per cancer death (mg) . . .
Total high energy teletherapy units / million inhabitants . . .
Number of radiotherapy centres
** No incidence data available. Figures are based on national incidence estimates from neighbouring countries.
* No mortality data available. Figures are based on national incidence estimates and modelled survival.
Tobacco control
Cancer Primary Prevention Policies
Has an operational cancer policy/strategy/action plan
Scope
ND
Hepatitis B vaccination schedule
Acetic acid visualization (VIA)
Mammogram
Bowel cancer screening by exam or colonoscopy
Radiotherapy
Number of radiation oncologists . . .
ND
